Foundations & Non-Profits
Partnering to advance awareness and prevention.
Foundations, charities, and non-profit organizations play a vital role in shaping the future of cancer care. From funding research to supporting patients and raising awareness, these groups bring trust, education, and community connection.
The miRoncol Real-time Multi-Cancer Early Risk Assessment provides an opportunity to collaborate on awareness, outreach, and education ensuring that individuals and families understand how molecular signals can complement existing screening and prevention strategies.
Why It Matters
- Cancer is the leading cause of death in Canada, yet more than 4 in 5 cancers are missed by current screening programs due to limited eligibility, low compliance rate and poor accessibility for areas lacking resources.
- Early awareness and prevention reduce the burden on patients, families, and the healthcare system.
- Foundations are uniquely positioned to bring equitable access and education to communities.
Opportunities for Collaboration
Education & Outreach
Co-develop materials to explain how molecular biology supports early cancer awareness.
Community Programs
Integrate early risk assessment into wellness, prevention, and survivorship initiatives.
Advocacy
Help shape the conversation on cancer prevention and the future of proactive healthcare.
Research Partnerships
Support studied projects, outreach studies, or awareness campaigns.
Foundation Support
miRoncol can co-design programs with foundations, including donations and in-kind support, to expand impact and reach.
Scientific Foundation
- Studies using 11,000+ human samples across multiple cancer types
- Specificity above 99% and high sensitivity for many common cancers
- Published in Cancers (2022) and Scientific Reports (2024)
- Based on microRNAs, the 2024 Nobel Prize in Medicine recognized discovery
Benefits for Foundations
- Contribute to public education on proactive cancer prevention
- Support equitable access to innovative risk assessment tools
- Build trust by aligning with science-driven, ethically grounded approaches
- Extend your mission with real-time molecular insights
Limitations & Ethics
miRoncol’s test is not diagnostic and is not a substitute for conventional screening programs. Partnerships must emphasize responsible communication and physician-guided interpretation.
Next Step
By partnering with miRoncol, foundations and non-profits can help bring meaningful early awareness to more people shaping a healthier future together.
